This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Litvinov, I. V. Articles by Isaacs, J. T. Search for Related Content PubMed PubMed Citation Articles by Litvinov, I. V. Articles by Isaacs, J. T.

Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells

¹ Chemical Therapeutics Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, ² Cellular and Molecular Medicine Graduate Program, and ³ The Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Requests for reprints: John T. Isaacs, Chemical Therapeutics Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Baltimore, MD 21231. Phone: 410-955-7777; Fax: 410-614-8397; E-mail: isaacjo{at}jhmi.edu.

Stage-specific differentiation markers were used to evaluate the cellular composition and the origin of nonimmortalized (PrEC) and immortalized (PZ-HPV7, CA-HPV10, RWPE-1, and 957E/hTERT) human prostate cell lines. These studies documented that immortalized and nonimmortalized prostate epithelial cells established and maintained in low (i.e., <300 µmol/L) Ca²⁺ serum-free defined (SFD) medium were all derived from normal nonmalignant prostate tissues and contain CD133⁺/ABCG2⁺/₂ß₁^Hi/p63^–/PSCA^–/AR^–/PSA^– prostate stem cells. In these cultures, prostate stem cells are able to self-renew and generate two distinct cell lineages: the minor proliferatively quiescent neuroendocrine lineage and the major transit-amplifying cell lineage. Subsequently, CD133^–/ABCG2^–/₂ß₁^Hi/p63⁺/PSCA^–/AR^–/PSA^– transit-amplifying cells proliferate frequently and eventually mature into proliferatively quiescent CD133^–/ABCG2^–/₂ß₁^Lo/p63^–/PSCA⁺/AR^–/PSA^– intermediate cells. Such proliferatively quiescent intermediate cells, however, do not complete their full maturation into CD133^–/ABCG2^–/₂ß₁^Lo/p63^–/PSCA^–/AR⁺/PSA⁺ luminal-secretory cells in low Ca²⁺ SFD medium. Addition of universal type I IFN and synthetic androgen (R1881) to culture medium resulted in up-regulation of androgen receptor protein expression. However, it failed to induce full differentiation of intermediate cells into AR⁺/PSA⁺ luminal-secretory cells. Our results indicate that such inability of prostate epithelial cells to complete their differentiation is due to continuous expression of Notch-1 receptor and its downstream effector, Hey-1 protein, which actively suppresses differentiation via its ability to transcriptionally repress a series of genes, including the GATA family of transcription factors. (Cancer Res 2006; 66(17): 8598-607)

This article has been cited by other articles:

				A. S. Goldstein, D. A. Lawson, D. Cheng, W. Sun, I. P. Garraway, and O. N. Witte Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics PNAS, December 30, 2008; 105(52): 20882 - 20887. [Abstract] [Full Text] [PDF]

				D. J. Vander Griend, W. L. Karthaus, S. Dalrymple, A. Meeker, A. M. DeMarzo, and J. T. Isaacs The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells Cancer Res., December 1, 2008; 68(23): 9703 - 9711. [Abstract] [Full Text] [PDF]

				N. Konishi, K. Shimada, M. Nakamura, E. Ishida, I. Ota, N. Tanaka, and K. Fujimoto Function of JunB in Transient Amplifying Cell Senescence and Progression of Human Prostate Cancer Clin. Cancer Res., July 15, 2008; 14(14): 4408 - 4416. [Abstract] [Full Text] [PDF]

				M. Mimeault, P. P. Mehta, R. Hauke, and S. K. Batra Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies Endocr. Rev., April 1, 2008; 29(2): 234 - 252. [Abstract] [Full Text] [PDF]

				L. Xin, R. U. Lukacs, D. A. Lawson, D. Cheng, and O. N. Witte Self-Renewal and Multilineage Differentiation In Vitro from Murine Prostate Stem Cells Stem Cells, November 1, 2007; 25(11): 2760 - 2769. [Abstract] [Full Text] [PDF]

				G. Gu, J. Yuan, M. Wills, and S. Kasper Prostate Cancer Cells with Stem Cell Characteristics Reconstitute the Original Human Tumor In vivo Cancer Res., May 15, 2007; 67(10): 4807 - 4815. [Abstract] [Full Text] [PDF]

				J. Miki, B. Furusato, H. Li, Y. Gu, H. Takahashi, S. Egawa, I. A. Sesterhenn, D. G. McLeod, S. Srivastava, and J. S. Rhim Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT-Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens Cancer Res., April 1, 2007; 67(7): 3153 - 3161. [Abstract] [Full Text] [PDF]